1 November 2022 true No description of principal activity Taxfiler 2023.12 OC340960business:LimitedLiabilityPartnershipLLP2022-11-012023-10-31 OC3409602022-10-31 OC340960business:EntityNoLongerTradingButTradedInPast2022-11-012023-10-31 OC3409602022-11-012023-10-31 OC340960business:AuditExempt-NoAccountantsReport2022-11-012023-10-31 OC340960business:FullAccounts2022-11-012023-10-31 OC3409602023-10-31 OC340960business:PartnerLLP12022-11-012023-10-31 OC340960business:PartnerLLP22022-11-012023-10-31 OC340960business:RegisteredOffice2022-11-012023-10-31 OC3409602022-10-31 OC340960core:RetainedEarningsAccumulatedLosses2023-10-31 OC340960core:RetainedEarningsAccumulatedLosses2022-10-31 OC340960business:SmallEntities2022-11-012023-10-31 OC340960countries:EnglandWales2022-11-012023-10-31 OC3409602021-11-012022-10-31 iso4217:GBP xbrli:pure
Registered No. OC340960 (England and Wales)
PHARMACORE INGENEERING LLP Unaudited accounts for the year ended 31 October 2023
PHARMACORE INGENEERING LLP LLP Information for the year ended 31 October 2023
Designated members
MONTER IMPEX LTD.
SOLTER MANAGEMENT LTD.
Registered Number
OC340960 (England and Wales)
Registered Office
85 GREAT PORTLAND STREET FIRST FLOOR LONDON W1W 7LT UNITED KINGDOM
- 2 -
PHARMACORE INGENEERING LLP Statement of financial position as at 31 October 2023
2023 
2022 
Notes
£ 
£ 
Current assets
Cash at bank and in hand
49,500 
49,500 
Net current assets
49,500 
49,500 
Net assets attributable to members
49,500 
49,500 
Represented by:
Members' other interests
Other reserves
49,500 
49,500 
49,500 
49,500 
Total members' interests
Members' other interests
49,500 
49,500 
49,500 
49,500 
For the year ending 31 October 2023 the LLP was entitled to exemption from audit under section 480 of the Companies Act 2006 (as applied to LLPs) relating to dormant LLPs.
The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 (as applied to LLPs) with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime. The profit and loss account has not been delivered to the Registrar of Companies.
Approved by the members on 7 February 2024.
MONTER IMPEX LTD. Designated member Limited Liability Partnership Registration No. OC340960
- 3 -
PHARMACORE INGENEERING LLP Notes to the Accounts for the year ended 31 October 2023
1
Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard) and the Statement of Recommended Practice (SORP), Accounting by Limited Liability Partnerships.
Presentation currency
The accounts are presented in £ sterling.
2
Statutory information
PHARMACORE INGENEERING LLP is a limited liability partnership, incorporated in England and Wales, registration number OC340960. Its registered office is 85 GREAT PORTLAND STREET, FIRST FLOOR, LONDON, W1W 7LT, UNITED KINGDOM.
Loans and other debts due to members rank equally with debts due to other unsecured creditors in the event of a winding up.
4
Average number of employees
During the year the average number of employees was 0 (2022: 0).
- 4 -